Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997 98.
about
Genome of the Bacterium Streptococcus pneumoniae Strain R6Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistanceDifferential Recognition and Hydrolysis of Host Carbohydrate Antigens by Streptococcus pneumoniae Family 98 Glycoside HydrolasesSurveillance for antimicrobial resistance in CroatiaUsing hospital antibiogram data to assess regional pneumococcal resistance to antibioticsPCR-based ordered genomic libraries: a new approach to drug target identification for Streptococcus pneumoniae.Blood group antigen recognition by a Streptococcus pneumoniae virulence factor.Antimicrobial-drug use and changes in resistance in Streptococcus pneumoniae.Eradication of common pathogens at days 2, 3 and 4 of moxifloxacin therapy in patients with acute bacterial sinusitisGenome evolution driven by host adaptations results in a more virulent and antimicrobial-resistant Streptococcus pneumoniae serotype 14Activities of clinafloxacin, gatifloxacin, gemifloxacin, and trovafloxacin against recent clinical isolates of levofloxacin-resistant Streptococcus pneumoniae.Genomic subtraction followed by dot blot screening of Streptococcus pneumoniae clinical and carriage isolates identifies genetic differences associated with strains that cause otitis media.Rapid automated antimicrobial susceptibility testing of Streptococcus pneumoniae by use of the bioMerieux VITEK 2.Use of penicillin MICs to predict in vitro activity of other beta-lactam antimicrobial agents against Streptococcus pneumoniae.Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage.Mechanisms of macrolide resistance in clinical pneumococcal isolates in France.Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States: 2-year longitudinal analysisAntimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999--2000, including a comparison of resistance rates since 1994--1995.Efficacies of ABT-773, a new ketolide, against experimental bacterial infections.Longitudinal assessment of antipneumococcal susceptibility in the United States.Comparative activities of the oxazolidinone AZD2563 and linezolid against selected recent North American isolates of Streptococcus pneumoniae.Measuring and interpreting associations between antibiotic use and penicillin resistance in Streptococcus pneumoniae.Pneumococcal resistance: the treatment challenge.The use of fluoroquinolones as antiinfective transition-therapy agents in community-acquired pneumonia.Antimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the United States.Aggregated antibiograms and monitoring of drug-resistant Streptococcus pneumoniaePneumococcal resistance to macrolides, lincosamides, ketolides, and streptogramin B agents: molecular mechanisms and resistance phenotypes.Pharmacokinetics and efficacy of linezolid in a gerbil model of Streptococcus pneumoniae-induced acute otitis media.Genetic relatedness of levofloxacin-nonsusceptible Streptococcus pneumoniae isolates from North America.Species-specific difference in antimicrobial susceptibility among viridans group streptococci.Activities of cethromycin and telithromycin against recent North American isolates of Streptococcus pneumoniaeReality of developing a community-wide antibiogram.Activity of daptomycin against recent North American isolates of Streptococcus pneumoniaeAppropriate use of antibiotics: focus on acute otitis media.Failure to control an outbreak of multidrug-resistant Streptococcus pneumoniae in a long-term-care facility: emergence and ongoing transmission of a fluoroquinolone-resistant strain.Reduced susceptibility to penicillin among pneumococci causing invasive infection in children - Canada, 1991 to 1998.Macrolide resistance in Streptococcus pneumoniae: Fallacy or fact?Implications of Streptococcus pneumoniae penicillin resistance and serotype distribution in Kuwait for disease treatment and prevention.Critical involvement of pneumolysin in production of interleukin-1alpha and caspase-1-dependent cytokines in infection with Streptococcus pneumoniae in vitro: a novel function of pneumolysin in caspase-1 activationOptimizing the management of community-acquired respiratory tract infections in the age of antimicrobial resistance.
P2860
Q22065464-42B1253C-7308-47EF-92A4-13C135E35656Q24548472-B96A3628-BDBD-4695-9346-F69DBC294C2DQ27656489-2440DA45-8C18-44BF-BE34-9711A3355681Q28366739-DAA404B0-85F8-4C01-A45B-29B0AD80C035Q30772203-AC246D65-0534-495B-BFA5-01933C8A6255Q30837212-54558BE5-D32B-465B-8280-D296852D3421Q31061712-5C5F46C1-69C0-4704-BF6E-6AAE33989EAEQ33181094-F811AE68-FDB7-4D35-984B-9AEBBE35C2E9Q33241517-9BD4F9C3-72D1-4175-BCBD-3897628C4CA6Q33429266-AE3F9AA8-24DE-4B66-8CEC-5E15C6979317Q33593776-B8CA5A4E-22A3-49C1-B228-F69277A79591Q33769043-5D4D47B7-9DD7-478C-9496-F4F73D0426C1Q33968677-84FA9E20-EBC5-4259-A412-AA523AE139CFQ33971039-20A5B85B-9757-432C-A9A8-22DA291DAC0AQ33980212-C407B70E-A941-4A85-95D5-E1FD096CC5E0Q33981528-D04F9F8A-B81E-44E2-B966-6ED61A538FC6Q33981832-8AF02BBE-811B-4F40-8F3B-8C6369AD3BDBQ33982256-07CFA5AF-EA2A-4D4B-81B2-774DA36C06BFQ33982950-FF8638BD-2B1F-49AF-947C-995CEE24B158Q34110932-588536E5-8BD2-48D9-BB2D-171E1D2645DBQ34112225-D7EFCDD4-3AE9-4F0F-9C8F-1B3BAF14890EQ34192567-FF0FCD17-4D6A-4725-8032-C96688E80EF5Q34219099-8605D254-BDAE-4AF4-A9BF-5313B1C76E56Q34304199-A3B8600B-4EC8-4D5E-869F-897FBC5B1464Q34347889-3424374C-18DE-47E7-BE28-56A6586A87F3Q34469936-C593960F-27E8-4A98-BFF8-11C4893935EAQ34547639-B708C6AE-31A5-485E-8D14-D68FB55AF677Q34883537-AAD695C0-78EF-4504-A5AB-C4111EDC6C69Q35026714-30C41767-1F86-4E10-A7A0-93BD7068C2EBQ35088472-DB9C622D-C855-4FF7-9B88-49BC3B16C54BQ35547345-C0E16078-1D3D-438E-9527-F7C63005229BQ35553403-1E2ED292-CFC0-478F-AD87-8AFA035E056AQ35685343-5DA58124-874A-41FD-9C4B-A96DB1C7DC05Q35760716-408E73B8-DB15-408F-8523-7DA85126F387Q36082806-F73D7AAD-5BD1-4F5C-BE7B-4DC150DC958FQ36170388-E7B9D366-7BA8-4406-B4C3-8206E5369F9EQ36170473-2A9118A1-1846-4534-A5B0-76AD39C443B0Q36452338-DF624EA4-0381-4BAE-812A-354161EE977DQ36539653-803AE9CF-28B0-4D8C-A577-1F67F4FF1F9EQ36670897-B0924E49-561C-42B1-957C-EABD366BCC63
P2860
Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997 98.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997 98.
@en
Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997 98.
@nl
type
label
Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997 98.
@en
Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997 98.
@nl
prefLabel
Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997 98.
@en
Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997 98.
@nl
P2093
P2860
P356
P1476
Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997 98
@en
P2093
P2860
P304
P356
10.3201/EID0506.990603
P577
1999-11-01T00:00:00Z